PI3K-IN-1 (Synonyms: XL-147 derivative 1)
目录号: PL09803 纯度: ≥96%
CAS No. :1349796-36-6
商品编号 规格 价格 会员价 是否有货 数量
PL09803-2mg 2mg ¥1205.00 请登录
PL09803-5mg 5mg ¥1928.00 请登录
PL09803-10mg 10mg ¥3214.00 请登录
PL09803-25mg 25mg ¥5625.00 请登录
PL09803-50mg 50mg ¥9643.00 请登录
PL09803-100mg 100mg ¥16876.00 请登录
PL09803-200mg 200mg 询价 询价
PL09803-500mg 500mg 询价 询价
PL09803-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2544.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
PI3K-IN-1
中文别名
N-[4-[[[3-[(3,5-二甲氧基苯基)氨基]-2-喹喔啉基]氨基]磺酰基]苯基]-3-甲氧基-4-甲基苯甲酰胺;SAR245409 (XL765) 抑制剂
英文名称
PI3K-IN-1
英文别名
XL765;SAR245409 (XL765);Benzamide, N-​[4-​[[[3-​[(3,​5-​dimethoxyphenyl)​amino]​-​2-​quinoxalinyl]​amino]​sulfonyl]​phenyl]​-​3-​methoxy-​4-​methyl-;SAR245409;xL019;PI3K-IN-1;Voxtalisib Analogue;XL 765;XL765 Analogue;N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide;Voxtalisib (SAR245409, XL765);Voxtalisib (SAR245409, XL765) Analogue;N-[2-[(3,5-Dimethoxyphenyl)amino]quinoxalin-3-yl]-4-[(4-methyl-3-methoxyphenyl)carbonyl]aminophenylsulfonamide;N-[4-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-met
Cas No.
1349796-36-6
分子式
C31H29N5O6S
分子量
599.66
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
PI3K-IN-1 (XL-147 derivative 1) 是一种有效的 PI3K 抑制剂,PI3K-IN-1 (25 μM) 可 阻断 PI3K/Akt 信号通路。
生物活性
PI3K-IN-1 (XL-147 derivative 1) is a potent inhibitor of PI3K. PI3K-IN-1 (25 μM) blocks PI3K/Akt signaling pathways.
性状
Solid
IC50 & Target[1][2]
PI3K
体外研究(In Vitro)
PI3K-IN-1 (25 μM) blocks PI3K/Akt signaling pathways. By using the PI3K inhibitor PI3K-IN-1, TGF-β1 induced transformation into myofibroblast is also inhibited, with relatively reduced expressions of α-SMA, Col-1 and Timp-1. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Mingyu Hao, et al. Exploring the Role of SRC in Extraocular Muscle Fibrosis of the Graves Ophthalmopathy. Front Bioeng Biotechnol. 2020 May 8;8:392.
溶解度数据
In Vitro: DMSO : 27.5 mg/mL (45.86 mM; Need ultrasonic and warming)H2O : < 0.1 mg/mL (insoluble)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2